Since the constants cannot be negative, it follows that K2 > K1. This analysis suggests that the 16 most likely pathway for the ligand-induced assembly of TLR9 dimers is first through saturation 17 of one of the binding sites with ligand to form 1:1 protein:DNA (PD) complexes, which then 18 assemble into 2:2 dimers (P2D2). However, this analysis assumes that the two binding sites are 19 independent. If this is incorrect and binding of the second ligand is cooperative, K2 could be 20 smaller than K1. 21
The microscopic binding constants for K3 are more complex than for K1 and K2. As expected, the hydrodynamic radii and molecular masses calculated from DLS data indicated 18 that mTLR9-ECD formed a 1:1 complex with the antagonist 4084, and 2:2 complexes with all 19 four agonistic oligonucleotides ( Fig. 2A-B) . The experimentally determined molecular 20 diameters of the complexes were slightly larger than expected, and the molecular masses 1 correspondingly smaller, because the DLS data were fitted to a globular model whereas 2 mTLR9-ECD has a non-globular horseshoe shape. The observed range in polydispersity, from 3 16% to 30%, could be due to small proportions of 1:1 complexes in the TLR9:agonist solutions. 4 To obtain a more direct measure of the mass of a TLR9 dimer, size-exclusion chromatography 7 coupled to multiangle light scattering (SEC-MALS) was performed on mTLR9 bound to 8 oligonucleotide 1668. As expected, the measured mass of 232 kDa was consistent with a 2:2 9 dimer ( Fig. 2C) . We note that the experimental hydrodynamic radii (Rh) determined from 10 SEC-MALS and DLS (5.3-5.6 nm) were approximately 10% larger than the theoretical radius 11 predicted from the TLR9:1668-12mer crystal structure (4.9 nm; Fig. 2D ). This slight 12 discrepancy could be due to the method used to calculate Rh (which was based on the root 13 mean square distance from the center of mass), or to the eight additional nucleotides in 1668 14 versus 1668-12mer, which were not taken into account. Cleavage of the ectodomain by an endosomal protease is necessary for dimerization but not for 8 ligand binding [11, 23, 24] . To confirm this in our system, FP was performed with uncleaved 9 mTLR9-ECD and Alexa Fluor 488-labeled 1668. The binding affinity was 6.9 ± 1.5 nM, with 10 a good fit to a 1:1 model curve, consistent with the expected inability of the uncleaved 11 (Fig. 3E) . Moreover, since uncleaved TLR9 cannot dimerize, this 1 binding affinity reports on only two of the macroscopic equilibrium constants defined in Fig.  2 1, K1 and K2. The slight deviation in the data from the theoretical fit (Fig. 3E) is likely due to 3 the presence of two ligand binding sites on TLR9, Sites A and B, which the crystal structure 4
suggests have different binding affinities [11] . Hence, early in the titration the ligand will 5 primarily bind the high-affinity site (Site A), with the low-affinity site (Site B) becoming 6 saturated with ligand last. 7
To deconvolute the contributions of the two ligand binding sites in mTLR9, two key residues 8 involved in ligand binding at Site B were mutated. The mutations, H616A and E641A, are 9 predicted to inhibit ligand binding at Site B. Since the H641A mutation alone abolished TLR9-10 dependent signaling in a cell-based assay [11], we also predicted that these mutations would 11 inhibit dimerization. Indeed, Alexa Fluor 488-labeled 1668 oligonucleotide bound mTLR9-12 H616A/E641A with an FP response curve fitting a 1:1 binding model similar to the binding 13 curve for uncleaved mTLR9 (Fig. 3F) , suggesting that the mutations in Site B prevent 14 dimerization. The binding affinity of mTLR9-H616A/E641A for 1668 was 27.7 ± 6.5 nM. This 15 provides to the affinity of oligonucleotide 1668 for Site A, which corresponds to the 16 microscopic constant KA. (Fig. 4A) . Next, we examined the equilibrium dynamics of this competition by 25 preincubating mTLR9 with fluorescently-labeled 1668-12mer, titrating in a molar excess of 1 unlabeled 4084, and monitoring displacement of 1668-12mer at various timepoints. 2 Unexpectedly, it took several hours for the competition conditions to reach equilibrium (Fig.  3   4B) . This was also true when the same experiment was performed using unlabeled 1668-12mer 4 instead of 4084 as the competing oligonucleotide (Fig. 4C) unexpectedly long time that it took ligand competition experiments to reach equilibrium 7 (several hours) revealed that dissociation of oligonucleotides from dimers is very slow, despite 8 the rate of dimer assembly being relatively rapid. We speculate that oligonucleotide 9 dissociation would be accompanied by TLR9 dimer dissociation. However, the role of auxiliary oligonucleotides is an important area for further study. In 24 particular, it will be important to examine whether 5'-xCx oligonucleotide binding at the 25 auxiliary site is independent of ligand binding at Sites A and B, and to determine the 1 mechanism through which auxiliary ligands promote dimerization. 2
In summary, a complete model for TLR9 binding is presented, and while there are many 3 solutions for the macroscopic equilibrium constants a priori, the experimental data presented 4 narrows the relationships between the macroscopic binding constants. To obtain a unique 5 solution for the complex 2:2 binding model of TLR9 to its ligands, further experimental or 6 numerical analyses are required. Since the activation of TLR9 is similar to the activation of 7 other TLRs, most notably TLR7 and TLR8, this work will help establish a more general model 8 of TLR activation, and hopefully guide future efforts to design TLR9 agonists or antagonists. 9
Materials and Methods 10

Expression and purification of recombinant mouse TLR9 ectodomain (mTLR9-ECD). A 11
pMT plasmid encoding mTLR9-ECD with a secretion signal and a C-terminal protein A tag 12 was a kind gift from Prof. Toshiyuki Shimizu. The Site B mutant was generated by site-directed 13 
